0001493152-23-029069.txt : 20230816 0001493152-23-029069.hdr.sgml : 20230816 20230816060246 ACCESSION NUMBER: 0001493152-23-029069 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230815 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20230816 DATE AS OF CHANGE: 20230816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sanara MedTech Inc. CENTRAL INDEX KEY: 0000714256 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 592220004 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39678 FILM NUMBER: 231176423 BUSINESS ADDRESS: STREET 1: 1200 SUMMIT AVE STREET 2: SUITE 414 CITY: FORT WORTH STATE: TX ZIP: 76102 BUSINESS PHONE: 817-529-2300 MAIL ADDRESS: STREET 1: 1200 SUMMIT AVE STREET 2: SUITE 414 CITY: FORT WORTH STATE: TX ZIP: 76102 FORMER COMPANY: FORMER CONFORMED NAME: WOUND MANAGEMENT TECHNOLOGIES, INC. DATE OF NAME CHANGE: 20080611 FORMER COMPANY: FORMER CONFORMED NAME: MB SOFTWARE CORP DATE OF NAME CHANGE: 19960805 FORMER COMPANY: FORMER CONFORMED NAME: INAV TRAVEL CORPORATION DATE OF NAME CHANGE: 19920703 8-K 1 form8-k.htm
0000714256 false 0000714256 2023-08-15 2023-08-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 15, 2023

 

SANARA MEDTECH INC.
(Exact name of registrant as specified in its charter)

 

Texas   001-39678   59-2219994
(State or other jurisdiction of   (Commission   (IRS Employer
incorporation)   File Number)   Identification No.)

 

1200 Summit Avenue, Suite 414

Fort Worth, Texas

   76102
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (817) 529-2300

 

(Former name or former address, if changed since last report)

 

Not Applicable

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     
  ☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     
  ☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

     
  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

   Name of each exchange on which registered
Common Stock, $0.001 par value   SMTI   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 7.01 Regulation FD Disclosure.

 

On August 15, 2023, Sanara MedTech Inc. (the “Company”) held a conference call announcing its financial results for the quarter ended June 30, 2023. During the conference call, in response to a question from an investor, the Company stated that the Company’s sales per facility were growing. To clarify, the Company’s response was based on sales per facility on a year-over-year basis when comparing the three and six months ended June 30, 2023 to the three and six months ended June 30, 2022. However, the Company’s sales per facility slightly declined on a quarter-over-quarter basis when comparing the three months ended June 30, 2023 to the three months ended March 31, 2023. The Company calculates monthly sales per facility by dividing (i) the Company’s aggregate monthly sales of CellerateRX® Surgical Activated Collagen®, FORTIFY TRG® Tissue Repair Graft, FORTIFY FLOWABLE® ECM, TEXAGEN® Amniotic Membrane Allograft, BiFORM® Bioactive Moldable Matrix, AMPLIFY™ Verified Inductive Bone Matrix and ALLOCYTE® Advanced Cellular Bone Matrix (the “Surgical Products”) by (ii) the number of facilities in which the Company generated revenue from sales of its Surgical Products during the month. The Company calculates quarterly sales per facility by averaging the Company’s sales per facility for each month of the quarter.

 

The information in Item 7.01 of this Current Report on Form 8-K is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section. Further, the information in Item 7.01 of this Current Report on Form 8-K shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filing. Item 7.01 of this Current Report on Form 8-K will not be deemed an admission as to the materiality of any information in this Current Report on Form 8-K that is required to be disclosed solely by Regulation FD.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:   August 16, 2023    
         
      Sanara MedTech Inc.
         
      By: /s/ Michael D. McNeil
      Name: Michael D. McNeil
      Title: Chief Financial Officer

 

 

 EX-101.PRE 2 smti-20230815_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.LAB 3 smti-20230815_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.SCH 4 smti-20230815.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
Aug. 15, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 15, 2023
Entity File Number 001-39678
Entity Registrant Name SANARA MEDTECH INC.
Entity Central Index Key 0000714256
Entity Tax Identification Number 59-2219994
Entity Incorporation, State or Country Code TX
Entity Address, Address Line One 1200 Summit Avenue
Entity Address, Address Line Two Suite 414
Entity Address, City or Town Fort Worth
Entity Address, State or Province TX
Entity Address, Postal Zip Code 76102
City Area Code (817)
Local Phone Number 529-2300
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value
Trading Symbol SMTI
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 form8-k_htm.xml IDEA: XBRL DOCUMENT 0000714256 2023-08-15 2023-08-15 iso4217:USD shares iso4217:USD shares 0000714256 false 8-K 2023-08-15 SANARA MEDTECH INC. TX 001-39678 59-2219994 1200 Summit Avenue Suite 414 Fort Worth TX 76102 (817) 529-2300 false false false false Common Stock, $0.001 par value SMTI NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://sanaramedtech.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm smti-20230815.xsd smti-20230815_lab.xml smti-20230815_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "smti-20230815_lab.xml" ] }, "presentationLink": { "local": [ "smti-20230815_pre.xml" ] }, "schema": { "local": [ "smti-20230815.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "SMTI", "nsuri": "http://sanaramedtech.com/20230815", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "AsOf2023-08-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://sanaramedtech.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "AsOf2023-08-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://sanaramedtech.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 13 0001493152-23-029069-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-029069-xbrl.zip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end